Tariffs could raise prices and limit access to Korean skincare products loved by U.S. consumers.
Denied emergency abortion care during miscarriage, a woman sues Catholic hospital in California.
Promising cancer immunotherapy study delayed due to NIH layoffs.
Massive cuts eliminated federal maternal and child health divisions and forced out a key director.
Federal research grants for women’s health are drying up under new Musk budget.
Critical care doctors reveal fatal consequences of abortion bans in new interviews.
Study identifies fast, simple method for predicting life-threatening postpartum bleeding.
New York Times honors the woman who funded and enabled the development of the birth control pill.
Mouse study reveals female hormones help trigger opioid production in spinal cord immune cells.
Women’s health startups raised $2.6B in VC funding last year, but exits remain elusive.
A new study finds fasting three days a week more effective than daily calorie restriction for weight loss.
The Daily Show co-creator uses satire to support abortion access and independent clinics.
The U.S. Supreme Court appears inclined to allow Medicaid patients to continue receiving non-abortion care from Planned Parenthood.
The Trump administration ends the Pregnancy Risk Assessment Monitoring System (PRAMS), a long-standing CDC data tool.
Ashley Parker writes about the emotional and medical realities of miscarriage, including how the term “abortion” appears in routine procedures.
A study from Intermountain Health finds heart outcome disparities between men and women are decreasing — but gaps in care remain.
The administration froze $35 million in Title X funding, reducing access to birth control and screenings for millions.
The New York Times dives into the ethics and limitations of using polygenic screening in IVF, highlighting the probabilistic nature of the predictions.
Breast pump startup Willow takes over UK-based Elvie’s assets, signaling tough market conditions for women’s health companies.
Mass layoffs hit federal health agencies, eliminating offices focused on vulnerable populations and raising alarms over public health preparedness.